New-generation 5-HT₄ receptor agonists: potential for treatment of gastrointestinal motility disorders

Author： Manabe Noriaki Wong Banny S Camilleri Michael

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.19, Iss.6, 2010-06, pp. : 765-775

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

5-HT 4 receptor agonists and bladder disorders - Pharmacological treatment of detrusor failure may be preferable to self-catheterization

By Tonini M. Candura S.M.

Trends in Pharmacological Sciences, Vol. 17, Iss. 9, 1996-09 ,pp. : 314-314

Elsevier

Access to resources Recommend Favorite

5-HT2C Receptor Agonists as Potential Drugs for the Treatment of Obesity

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 8, 2003-05 ,pp. : 885-897

Bentham Science Publishers

Access to resources Recommend Favorite

New 5-HT2C receptor agonists

By Bishop Michael J Nilsson Björn M

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 11, 2003-11 ,pp. : 1691-1705

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Potential of 5-HT2C Receptor Antagonists in the Treatment of Anxiety Disorders

Current Drug Targets-CNS & Neurological Disorders, Vol. 2, Iss. 6, 2003-12 ,pp. : 383-387

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of 5-HT 1A and 5-HT 2 receptor agonists on the behavioral and neurochemical consequences of repeated nicotine treatment

By Olausson P. Åkesson P. Engel J.A. Soderpalm B.

European Journal of Pharmacology, Vol. 420, Iss. 1, 2001-05 ,pp. : 45-54

Elsevier

Access to resources Recommend Favorite